Zhengye Biotechnology Holding Ltd
About Zhengye Biotechnology Holding Ltd
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $16.6M
- Net income
- -$10.0M
- Total assets
- $62.4M
- Market cap
- $39.4M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $39.4M
- Shares outstanding
- 45.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jan 7, 2025
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $10.0M in FY2025.
- Trading 94% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Zhengye Biotechnology Holding Ltd.
Write a review
News about Zhengye Biotechnology Holding Ltd
News & sentiment via Polygon.io
